CUMS increased the concentration of pro-apoptosis factor, while the combination of CUMS and smoke exacerbated these changes by increasing inflammation and dysfunction of BDNF syste... by Bai-Ping Liu (14164799)

Workflow for multi-modal imaging of HSV-1 infected cells. by Kamal L. Nahas (13014698)

Soft X-ray tomography imaging at cryogenic temperatures of HSV-1-infected HFF-hTERT cells identifies virus particles. by Kamal L. Nahas (13014698)

Coral juvenile abundance of the most abundant taxa across locations and years. by Anna Koester (11805572)

Dietary supplements use by patients with CIBD. by Maha Hoteit (11589163)

“…<div><p>Background/Aims</p><p>Chronic inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis are known for a combination of food intolerance, decreased oral intake, and malabsorption which all predispose patients to malnutrition and suboptimal dietary intake. …”

Socioeconomic characteristics of the sample. by Maha Hoteit (11589163)

“…<div><p>Background/Aims</p><p>Chronic inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis are known for a combination of food intolerance, decreased oral intake, and malabsorption which all predispose patients to malnutrition and suboptimal dietary intake. …”

Remodelling of mitochondria during HSV-1 infection. by Kamal L. Nahas (13014698)

S1 Data set - by Kalayou K. Berhe (16884067)

“…Patients with government employment (AOR = 0.48; 95% CI 0.26, 0.90), antiplatelet drug use (AOR = 0.29; 95% CI 0.16, 0.52), and medication for treating dyslipidemia (AOR = 0.54; 95% CI 0.35, 0.84), all had a decreased chance of developing a chronic diabetes problem.…”

<i>as-</i>APF increases p53 expression by modulating USP2a and MDM2 in TRT-HU1, immortalized human normal bladder epithelial cells. by Jayoung Kim (153487)

“…(<b>B</b>) Endogenous USP2a level is rapidly decreased in response to <i>as</i>-APF treatment in TRT-HU1 cells. …”

Coral juvenile abundance across locations and years. by Anna Koester (11805572)

Results of coral recruit study. by Anna Koester (11805572)

Acceptance of the HPV vaccine. by Mohammad Delwer Hossain Hawlader (11558838)

“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”

Cues to the action question. by Mohammad Delwer Hossain Hawlader (11558838)

“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”

Characteristics of the respondents (n = 2,151). by Mohammad Delwer Hossain Hawlader (11558838)

“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”

Determinants of HPV vaccine acceptance. by Mohammad Delwer Hossain Hawlader (11558838)

“…After adjustment for other factors, it was found that higher age was associated with a decreased acceptance (AOR: 0.92; 95% CI: 0.89–0.95). …”

Temporal analysis of HSV-1 infection using the dual-fluorescent timestamp virus. by Kamal L. Nahas (13014698)

Total number of hospitalizations and hospitalization rates for HAV infection by age groups in Mexico throughout the observation period (2000–2019). by Adriana Guzman-Holst (7906868)

Deaths due to HAV infection by year and age group in Mexico throughout the observation period (2000–2019). by Adriana Guzman-Holst (7906868)

Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

“…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”